XBIOTECH INC (XBIT) Forecast, Price Target & Analyst Ratings

NASDAQ:XBIT • CA98400H1029

Current stock price

2.35 USD
+0.01 (+0.43%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XBIOTECH INC (XBIT).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of $2.35 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

XBIT Current Analyst RatingXBIT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

XBIT Historical Analyst RatingsXBIT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
XBIT was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about XBIT.
In the previous month the buy percentage consensus was at a similar level.
XBIT was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
XBIT revenue by date.XBIT revenue by date.
44M18.39M
-58.20%		4.01M
-78.19%		N/A
-100.00%		N/AN/A
EBITDA
YoY % growth
XBIT ebitda by date.XBIT ebitda by date.
-16.04M
44.44%		-22.43M
-39.84%		-31.88M
-42.13%		N/A
-12.19%		N/A
-12.55%		N/A
EBIT
YoY % growth
XBIT ebit by date.XBIT ebit by date.
-18.28M
41.47%		-25.08M
-37.20%		-34.49M
-37.52%		N/A
-8.76%		N/A
-11.97%		N/A
Operating Margin
XBIT operating margin by date.XBIT operating margin by date.
-41.55%-136.38%-860.10%N/AN/AN/A
EPS
YoY % growth
XBIT eps by date.XBIT eps by date.
N/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

XBIT Yearly Revenue VS EstimatesXBIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 10M 20M 30M 40M
XBIT Yearly EPS VS EstimatesXBIT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2019 0 5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

XBIOTECH INC / XBIT Forecast FAQ

Can you provide the upcoming earnings date for XBIOTECH INC?

XBIOTECH INC (XBIT) will report earnings on 2026-05-12.

Can you provide the analyst count for XBIOTECH INC stock?

The number of analysts covering XBIOTECH INC (XBIT) is 7.